Displaying 851 - 900 of 185763 results
Released Company Title Industry Topic
22 Oct 2024
07:30 CEST
EVERFUEL MINIMUM ACCEPTANCE CONDITION SATISFIED FOR THE UNREGULATED RECOMMENDED VOLUNTARY CASH OFFER OF NOK 13 PER SHARE TO THE SHAREHOLDERS OF EVERFUEL A/S 60102010 Alternative Fuels Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:30 CEST
- Un péage poids lourds sans barrière mis en service en Espagne - Other subject
22 Oct 2024
07:30 CEST
EXOSENS Exosens announces agreement to acquire NVLS (Night Vision Laser Spain), specialist in night vision equipment 50202025 Electronic Equipment: Gauges and Meters Mergers, Acquiqitions, Transferts
22 Oct 2024
07:30 CEST
Eika Gruppen AS Fremtind Holding konsern - Resultat 3. kvartal 2024 og hittil i år - Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
SpareBank 1 Sør-Norge ASA SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
Boussard Gavaudan BGHL (EUR): NAV(s) 30204000 Closed End Investments Other subject
22 Oct 2024
07:30 CEST
SpareBank 1 Østlandet SpareBank 1 Østlandet (SPOL): SpareBank 1 Gruppen – 3Q 2024 Results 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:30 CEST
SpareBank 1 SMN SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
SPAREBANK 1 HELGELAND SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
SpareBank 1 Ringerike Hadeland SpareBank 1 Ringerike Hadeland: SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
CROSSJECT Crossject annonce des progrès majeurs dans la fabrication de son traitement d’urgence ZEPIZURE®, pour la prise en charge des crises d’épilepsie, à l’approche du dépôt d’une demande d’autorisation d’utilisation d’urgence aux États-Unis. 20102010 Medical Equipment -
22 Oct 2024
07:30 CEST
SpareBank 1 Nord-Norge SpareBank 1 Gruppen – Q3 2024 Results 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:30 CEST
EXOSENS Exosens signe un accord en vue d’acquérir NVLS (Night Vision Laser Spain), un spécialiste des équipements de vision nocturne 50202025 Electronic Equipment: Gauges and Meters Mergers, Acquiqitions, Transferts
22 Oct 2024
07:30 CEST
SpareBank 1 Sogn og Fjordane SpareBank 1 Gruppen - resultat 3. kvartal 2024 og resultateffekt for SpareBank 1 Sogn og Fjordane - Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
SpareBank 1 Sør-Norge ASA SpareBank 1 Gruppen – Q3 2024 Results 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:30 CEST
BOUSSARD GAVAUDAN HOLD LTD GBP BGHL (GBP): NAV(s) 30204000 Closed End Investments Other subject
22 Oct 2024
07:30 CEST
Eika Forsikring AS 15/45 FRN STEP C SUB Tredje kvartal 2024 - Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
SpareBank 1 SMN SpareBank 1 Gruppen – Q3 2024 Results 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:30 CEST
SPAREBANK 1 HELGELAND SpareBank 1 Gruppen – Q3 2024 Results 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:30 CEST
SpareBank 1 Østlandet SpareBank 1 Østlandet (SPOL): SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
SpareBank 1 Nordmøre SNOR: SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
SpareBank 1 Østfold Akershus SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:30 CEST
CROSSJECT Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization 20102010 Medical Equipment -
22 Oct 2024
07:30 CEST
BW ENERGY LIMITED BW Energy: Q3 2024 trading update  60101010 Oil: Crude Producers Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:30 CEST
SpareBank 1 Nord-Norge SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Oct 2024
07:15 CEST
EUROFINS SCIENTIFIC Eurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma Pipelines 20102020 Medical Services Sales
22 Oct 2024
07:15 CEST
EUROFINS SCIENTIFIC Eurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations Regarding Transactions That Occurred Between 10 and 25 Years Ago 20102020 Medical Services New
22 Oct 2024
07:00 CEST
VÅR ENERGI ASA Key information relating to cash dividend to be paid by Vår Energi ASA 60101015 Offshore Drilling and Other Services Additional regulated information required to be disclosed under the laws of a Member State
22 Oct 2024
07:00 CEST
Tomra Systems ASA TOMRA: 3Q 2024: 15% increase in EBITA adj. with strong quarter in Collection, good progress on the improvement program in Food, and stable development in Recycling 50204000 Machinery: Industrial Half yearly financial reports and audit reports/limited reviews
22 Oct 2024
07:00 CEST
VÅR ENERGI ASA Vår Energi reports strong financial results in the third quarter 2024 60101015 Offshore Drilling and Other Services Half yearly financial reports and audit reports/limited reviews
22 Oct 2024
07:00 CEST
VÅR ENERGI ASA Vår Energi unlocking high-value barrels in the Balder area 60101015 Offshore Drilling and Other Services Non-regulatory press releases
22 Oct 2024
07:00 CEST
Gjensidige Forsikring ASA Higher insurance service result driven by revenue growth 30302010 Full Line Insurance Half yearly financial reports and audit reports/limited reviews
22 Oct 2024
07:00 CEST
Gjensidige Forsikring ASA Høyere forsikringsresultat drevet av inntektsvekst 30302010 Full Line Insurance Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
22 Oct 2024
07:00 CEST
GIGANTE SALMON AS Gigante Salmon AS: Publisering av kvartalsrapport Q3 45102010 Farming, Fishing, Ranching and Plantations Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
22 Oct 2024
07:00 CEST
GIGANTE SALMON AS Gigante Salmon AS: Publication of Q3 Report 45102010 Farming, Fishing, Ranching and Plantations Half yearly financial reports and audit reports/limited reviews
22 Oct 2024
07:00 CEST
INTERPARFUMS Q3 2024 sales: €258m (+20%) 40204035 Cosmetics Share history
22 Oct 2024
07:00 CEST
INTERPARFUMS Chiffre d\'affaires 3ème trimestre 2024 : 258 M€ (+20 %) 40204035 Cosmetics Share history
21 Oct 2024
21:41 CEST
ATLANTIC SAPPHIRE Atlantic Sapphire ASA: New share capital registered 45102010 Farming, Fishing, Ranching and Plantations Total number of voting rights and capital
21 Oct 2024
21:30 CEST
NORDEA BANK Nordea Bank Abp: Repurchase of own shares on 21.10.2024 30101010 Banks Acquisition or disposal of the issuer’s own shares
21 Oct 2024
21:30 CEST
AEGA AEGA ASA - Mandatory notification of sale of shares by primary insider 30202000 Diversified Financial Services Mandatory notification of trade primary insiders
21 Oct 2024
21:30 CEST
AEGA Aega ASA - Mandatory notification of sale of shares by close associate to primary insider 30202000 Diversified Financial Services Mandatory notification of trade primary insiders
21 Oct 2024
21:23 CEST
FACEPHI Interim Financial Information 30-6-2024 and Results Report 10101015 Software Commercial results
21 Oct 2024
21:17 CEST
Schibsted ASA Schibsted ASA (SCHA/SCHB) - Repurchase of own shares 10101020 Consumer Digital Services Acquisition or disposal of the issuer’s own shares
21 Oct 2024
21:01 CEST
GREENVOLT ENERGIAS RENOVAVEIS S.A. Greenvolt - Energias Renováveis, S.A. announces qualifying holdings 65101010 Alternative Electricity Change in Capital
21 Oct 2024
21:00 CEST
GREENVOLT ENERGIAS RENOVAVEIS S.A. Greenvolt - Energias Renováveis, S.A. informa sobre participação qualificada 65101010 Alternative Electricity Change in Capital
21 Oct 2024
20:58 CEST
GREENVOLT ENERGIAS RENOVAVEIS S.A. Greenvolt - Energias Renováveis, S.A. announces qualifying holdings 65101010 Alternative Electricity Change in Capital
21 Oct 2024
20:58 CEST
GREENVOLT ENERGIAS RENOVAVEIS S.A. Greenvolt - Energias Renováveis, S.A. informa sobre participação qualificada 65101010 Alternative Electricity Change in Capital
21 Oct 2024
20:00 CEST
ABIONYX PHARMA ABIONYX Pharma Received Positive Feedback from the EMA for CER-001 in LCAT Deficiency 20103010 Biotechnology Other subject
21 Oct 2024
20:00 CEST
ABIONYX PHARMA ABIONYX Pharma reçoit un avis positif de l'EMA pour le CER-001 dans la Déficience en LCAT 20103010 Biotechnology Other subject
21 Oct 2024
19:30 CEST
VEON VEON Welcomes Letter from its Shareholder Shah Capital, Reiterates Commitment to Shareholder Value Creation 15102015 Telecommunications Services Other subject